Mucocutaneous Lymph Node Syndrome
"Mucocutaneous Lymph Node Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.
| Descriptor ID |
D009080
|
| MeSH Number(s) |
C14.907.940.560 C15.604.560 C17.800.862.560
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mucocutaneous Lymph Node Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Mucocutaneous Lymph Node Syndrome".
This graph shows the total number of publications written about "Mucocutaneous Lymph Node Syndrome" by people in this website by year, and whether "Mucocutaneous Lymph Node Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2014 | 3 | 0 | 3 |
| 2016 | 5 | 0 | 5 |
| 2017 | 26 | 2 | 28 |
| 2018 | 26 | 4 | 30 |
| 2019 | 8 | 0 | 8 |
| 2020 | 44 | 18 | 62 |
| 2021 | 18 | 4 | 22 |
To return to the timeline, click here.
Below are the most recent publications written about "Mucocutaneous Lymph Node Syndrome" by people in Profiles.
-
No Increase in Kawasaki Disease-Like Illnesses During the COVID-19 Pandemic Compared With 4 Previous Years: A Medical Records Review Analysis. J Clin Rheumatol. 2022 03 01; 28(2):e623-e625.
-
Guide for cardiological referral for patients with paediatric multisystemic inflammatory syndrome and Kawasaki disease associated with SARS-CoV-2 Arch Cardiol Mex. 2021 Dec 20; 91(Suplemento COVID):040-046.
-
Learning about Kawasaki disease from COVID-19 and the Multisystem Inflammatory Syndrome in Children. Curr Opin Pediatr. 2021 12 01; 33(6):603-609.
-
Kawasaki Disease Hospitalizations in the United States 2016-2020: A Comparison of Before and During the Coronavirus Disease 2019 Era. Pediatr Infect Dis J. 2021 11 01; 40(11):e407-e412.
-
The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. J Clin Invest. 2021 10 15; 131(20).
-
Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C. J Clin Invest. 2021 10 15; 131(20).
-
Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review. Rheumatology (Oxford). 2021 10 02; 60(10):4530-4537.
-
Response to 'COVID-19-associated multisystem inflammatory syndrome in adults with Kawasaki disease-like cutaneous manifestations': reply from the authors. Br J Dermatol. 2021 10; 185(4):872-873.
-
Clinical features of multisystem inflammatory syndrome in children. Curr Opin Rheumatol. 2021 09 01; 33(5):378-386.
-
The Impact of Social Distancing for COVID-19 Upon Diagnosis of Kawasaki Disease. J Pediatric Infect Dis Soc. 2021 Aug 14; 10(6):742-744.